#1 Startup Dataset
Growth rates, revenue data, direct competitors and contact details.
Paul Berns Email
Executive Chair . BlackThorn Therapeutics
How to contact Paul Berns
Join and see Paul's contact info for free!Current Roles
Employees:
2Revenue:
$155kAbout
BlackThorn Therapeutics is a neurobehavioral health company developing targeted therapeutics, informed by a deep understanding of brain and behavior relationships, to significantly improve patient outcomes. The company has pioneered a proprietary computational psychiatry platform, which leverages bioinformatics, neuroinformatics and artificial intelligence technologies, with the goal of determining a patient's distinct neuroprint to inform the proper on-target treatment option for biologically defined patient subtypes. BlackThorn Therapeutics has completed a Phase 1 trial of BTRX-335140, a selective kappa opioid receptor antagonist, and is conducting IND-enabling studies for BTRX-323511, a selective vasopressin 1a receptor antagonist. The company also has a drug discovery program directed at novel therapeutic targets for neurobehavioral disorders. BlackThorn Therapeutics is headquartered in San Francisco, California. For more information, please visit http://www.blackthornrx.com.BlackThorn Therapeutics Address
780 Brannan StSan Francisco, CA
United States